These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9347380)

  • 21. Effects of mianserin on negative symptoms in schizophrenia.
    Mizuki Y; Kajimura N; Imai T; Suetsugi M; Kai S; Kaneyuki H; Yamada M
    Int Clin Psychopharmacol; 1990 Apr; 5(2):83-95. PubMed ID: 1696292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of anti-serotoninergic agents in the treatment of erectile dysfunction.
    Kurt U; Ozkardeş H; Altuğ U; Germiyanoğlu C; Gürdal M; Erol D
    J Urol; 1994 Aug; 152(2 Pt 1):407-9. PubMed ID: 8015082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is diltiazem effective in treating the symptoms of (tardive) dyskinesia in chronic psychiatric inpatients? A negative, double-blind, placebo-controlled trial.
    Loonen AJ; Verwey HA; Roels PR; van Bavel LP; Doorschot CH
    J Clin Psychopharmacol; 1992 Feb; 12(1):39-42. PubMed ID: 1348061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study.
    Miodownik C; Lerner V; Statsenko N; Dwolatzky T; Nemets B; Berzak E; Bergman J
    Clin Neuropharmacol; 2006; 29(2):68-72. PubMed ID: 16614537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is melatonin treatment effective for tardive dyskinesia?
    Shamir E; Barak Y; Plopsky I; Zisapel N; Elizur A; Weizman A
    J Clin Psychiatry; 2000 Aug; 61(8):556-8. PubMed ID: 10982197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trazodone in burning mouth pain: a placebo-controlled, double-blind study.
    Tammiala-Salonen T; Forssell H
    J Orofac Pain; 1999; 13(2):83-8. PubMed ID: 10425979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin E treatment of tardive dyskinesia.
    Adler LA; Peselow E; Rotrosen J; Duncan E; Lee M; Rosenthal M; Angrist B
    Am J Psychiatry; 1993 Sep; 150(9):1405-7. PubMed ID: 8102511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
    Lohr JB; Caligiuri MP
    J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin.
    van Heeringen K; Zivkov M
    Br J Psychiatry; 1996 Oct; 169(4):440-3. PubMed ID: 8894194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical activity and tolerability of trazodone, mianserin, and amitriptyline in elderly subjects with major depression: a controlled multicenter trial.
    Altamura AC; Mauri MC; Rudas N; Carpiniello B; Montanini R; Perini M; Scapicchio PL; Hadjchristos C; Carucci G; Minervini M
    Clin Neuropharmacol; 1989; 12 Suppl 1():S25-33; S34-7. PubMed ID: 2663151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
    Davidson M; Saoud J; Staner C; Noel N; Luthringer E; Werner S; Reilly J; Schaffhauser JY; Rabinowitz J; Weiser M; Luthringer R
    Am J Psychiatry; 2017 Dec; 174(12):1195-1202. PubMed ID: 28750582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind study of trazodone and mianserin in the treatment of depression in general practice.
    Richards HH; Midha RN; Miller S
    J Int Med Res; 1982; 10(3):147-56. PubMed ID: 7047257
    [No Abstract]   [Full Text] [Related]  

  • 35. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial.
    Anderson KE; Stamler D; Davis MD; Factor SA; Hauser RA; Isojärvi J; Jarskog LF; Jimenez-Shahed J; Kumar R; McEvoy JP; Ochudlo S; Ondo WG; Fernandez HH
    Lancet Psychiatry; 2017 Aug; 4(8):595-604. PubMed ID: 28668671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin.
    Tanum L; Malt UF
    Scand J Gastroenterol; 1996 Apr; 31(4):318-25. PubMed ID: 8726297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in tardive dyskinesia symptoms in elderly patients treated with ganglioside GM1 or placebo.
    Sommer BR; Cohen BM; Satlin A; Cole JO; Jandorf L; Dorsey F
    J Geriatr Psychiatry Neurol; 1994; 7(4):234-7. PubMed ID: 7826493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study.
    Stryjer R; Rosenzcwaig S; Bar F; Ulman AM; Weizman A; Spivak B
    Clin Neuropharmacol; 2010; 33(5):219-22. PubMed ID: 20838215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study.
    Poyurovsky M; Koren D; Gonopolsky I; Schneidman M; Fuchs C; Weizman A; Weizman R
    Eur Neuropsychopharmacol; 2003 Mar; 13(2):123-8. PubMed ID: 12650957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.